Pathfinder Cell Therapy, Inc. (PFND)

0.0000 0.00 (0.00%) USD  |  OTCM  |  Feb 27, 16:00
More

Pathfinder Cell Therapy EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for PFND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Athersys, Inc. --
Infinity Pharmaceuticals, Inc. --
Seelos Therapeutics, Inc. --
Eloxx Pharmaceuticals, Inc. --
Marizyme, Inc. --